Dasatinib intermediate 4

SL-8124

Dasatinib intermediate 4, >98%

CAS No. : [910297-70-0]

IUPAC Name : 3-Chloro-2-(2-((6-chloro-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamido)benzyl pivalate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
250MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
500MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an advanced key intermediate in the synthesis of Dasatinib, which is a dual Bcr-Abl and Src family tyrosine kinase inhibitor. Dasatinib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells) as a first treatment.

References : Kovackova S. et al.: J. Med. Chem., 58(8), 3393-3410, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.